RSS

p53

A new study from industry and academia has highlighted a new approach to targeting key cancer-linked proteins that are considered to be ‘undruggable’. more

News

Almac has launched a CLIA sequencing test for P53 mutations; P53 is considered a key biomarker for cancer drug discoveries. more

News